Stockreport

Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept

Opthea Limited - American Depositary Shares  (OPT) 
PDF COAST trial is evaluating the superiority of sozinibercept combined with EYLEA® (aflibercept) over EYLEA alone in wet AMD Enrollment of second pivotal trial (ShORe) to [Read more]